Literature DB >> 26185269

Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.

Ayal Schaffer1, Erkki T Isometsä2, Leonardo Tondo3, Doris H Moreno4, Mark Sinyor5, Lars Vedel Kessing6, Gustavo Turecki7, Abraham Weizman8, Jean-Michel Azorin9, Kyooseob Ha10, Catherine Reis11, Frederick Cassidy12, Tina Goldstein13, Zoltán Rihmer14, Annette Beautrais15, Yuan-Hwa Chou16, Nancy Diazgranados17, Anthony J Levitt5, Carlos A Zarate18, Lakshmi Yatham19.   

Abstract

OBJECTIVES: Bipolar disorder is associated with elevated risk of suicide attempts and deaths. Key aims of the International Society for Bipolar Disorders Task Force on Suicide included examining the extant literature on epidemiology, neurobiology and pharmacotherapy related to suicide attempts and deaths in bipolar disorder.
METHODS: Systematic review of studies from 1 January 1980 to 30 May 2014 examining suicide attempts or deaths in bipolar disorder, with a specific focus on the incidence and characterization of suicide attempts and deaths, genetic and non-genetic biological studies and pharmacotherapy studies specific to bipolar disorder. We conducted pooled, weighted analyses of suicide rates.
RESULTS: The pooled suicide rate in bipolar disorder is 164 per 100,000 person-years (95% confidence interval = [5, 324]). Sex-specific data on suicide rates identified a 1.7:1 ratio in men compared to women. People with bipolar disorder account for 3.4-14% of all suicide deaths, with self-poisoning and hanging being the most common methods. Epidemiological studies report that 23-26% of people with bipolar disorder attempt suicide, with higher rates in clinical samples. There are numerous genetic associations with suicide attempts and deaths in bipolar disorder, but few replication studies. Data on treatment with lithium or anticonvulsants are strongly suggestive for prevention of suicide attempts and deaths, but additional data are required before relative anti-suicide effects can be confirmed. There were limited data on potential anti-suicide effects of treatment with antipsychotics or antidepressants.
CONCLUSION: This analysis identified a lower estimated suicide rate in bipolar disorder than what was previously published. Understanding the overall risk of suicide deaths and attempts, and the most common methods, are important building blocks to greater awareness and improved interventions for suicide prevention in bipolar disorder. Replication of genetic findings and stronger prospective data on treatment options are required before more decisive conclusions can be made regarding the neurobiology and specific treatment of suicide risk in bipolar disorder. © The Royal Australian and New Zealand College of Psychiatrists 2015.

Entities:  

Keywords:  Bipolar disorder; neurobiology; pharmacotherapy; prevalence; suicide or suicide attempts

Mesh:

Substances:

Year:  2015        PMID: 26185269      PMCID: PMC5116383          DOI: 10.1177/0004867415594427

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  171 in total

1.  Race/ethnicity, substance abuse, and mental illness among suicide victims in 13 US states: 2004 data from the National Violent Death Reporting System.

Authors:  D L Karch; L Barker; T W Strine
Journal:  Inj Prev       Date:  2006-12       Impact factor: 2.399

2.  Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population.

Authors:  Regina Sala; Benjamin I Goldstein; Carmen Morcillo; Shang-Min Liu; Mariela Castellanos; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2012-04-24       Impact factor: 4.791

Review 3.  Biochemical studies in suicide victims: current findings and future implications.

Authors:  M Stanley; B Stanley
Journal:  Suicide Life Threat Behav       Date:  1989

4.  A comparison of the medical lethality of suicide attempts in bipolar and major depressive disorders.

Authors:  Gil Zalsman; Melanie Braun; Mikkel Arendt; Michael F Grunebaum; Leo Sher; Ainsley K Burke; David A Brent; Sadia R Chaudhury; J John Mann; Maria A Oquendo
Journal:  Bipolar Disord       Date:  2006-10       Impact factor: 6.744

5.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; Serge Beaulieu; Martin Alda; Claire O'Donovan; Glenda Macqueen; Roger S McIntyre; Verinder Sharma; Arun Ravindran; L Trevor Young; Roumen Milev; David J Bond; Benicio N Frey; Benjamin I Goldstein; Beny Lafer; Boris Birmaher; Kyooseob Ha; Willem A Nolen; Michael Berk
Journal:  Bipolar Disord       Date:  2012-12-12       Impact factor: 6.744

6.  The European Psychiatric Association (EPA) guidance on suicide treatment and prevention.

Authors:  D Wasserman; Z Rihmer; D Rujescu; M Sarchiapone; M Sokolowski; D Titelman; G Zalsman; Z Zemishlany; V Carli
Journal:  Eur Psychiatry       Date:  2011-12-01       Impact factor: 5.361

7.  Suicide risk in bipolar disorder during treatment with lithium and divalproex.

Authors:  Frederick K Goodwin; Bruce Fireman; Gregory E Simon; Enid M Hunkeler; Janelle Lee; Dennis Revicki
Journal:  JAMA       Date:  2003-09-17       Impact factor: 56.272

Review 8.  Suicidal behaviour in bipolar disorder: risk and prevention.

Authors:  Leonardo Tondo; Göran Isacsson; Ross Baldessarini
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.

Authors:  Jon C Collins; Bentson H McFarland
Journal:  J Affect Disord       Date:  2007-08-16       Impact factor: 4.839

10.  Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.

Authors:  S G Fillman; D Sinclair; S J Fung; M J Webster; C Shannon Weickert
Journal:  Transl Psychiatry       Date:  2014-02-25       Impact factor: 6.222

View more
  19 in total

1.  Suicidality in Bipolar Disorder: The Role of Emotion-Triggered Impulsivity.

Authors:  Sheri L Johnson; Charles S Carver; Jordan A Tharp
Journal:  Suicide Life Threat Behav       Date:  2016-07-13

2.  Prediction of near-term increases in suicidal ideation in recently depressed patients with bipolar II disorder using intensive longitudinal data.

Authors:  Colin A Depp; Wesley K Thompson; Ellen Frank; Holly A Swartz
Journal:  J Affect Disord       Date:  2016-10-18       Impact factor: 4.839

3.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

4.  Preliminary examination of gray and white matter structure and longitudinal structural changes in frontal systems associated with future suicide attempts in adolescents and young adults with mood disorders.

Authors:  Elizabeth T Cox Lippard; Jennifer A Y Johnston; Linda Spencer; Susan Quatrano; Siyan Fan; Anjali Sankar; Judah Weathers; Brian Pittman; Maria A Oquendo; Hilary P Blumberg
Journal:  J Affect Disord       Date:  2018-11-28       Impact factor: 4.839

Review 5.  Medication nonadherence in bipolar disorder: a narrative review.

Authors:  Ibrahim Jawad; Stuart Watson; Peter M Haddad; Peter S Talbot; R Hamish McAllister-Williams
Journal:  Ther Adv Psychopharmacol       Date:  2018-10-16

6.  Familial Aggregation and Coaggregation of Suicide Attempts and Comorbid Mental Disorders in Adults.

Authors:  Elizabeth D Ballard; Lihong Cui; Caroline Vandeleur; Enrique Castelao; Carlos A Zarate; Martin Preisig; Kathleen Ries Merikangas
Journal:  JAMA Psychiatry       Date:  2019-08-01       Impact factor: 21.596

Review 7.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

Review 8.  Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment.

Authors:  Leonardo Tondo; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2016-09       Impact factor: 5.285

9.  Symptom trajectories in the months before and after a suicide attempt in individuals with bipolar disorder: A STEP-BD study.

Authors:  Elizabeth D Ballard; Cristan A Farmer; Bridget Shovestul; Jennifer Vande Voort; Rodrigo Machado-Vieira; Lawrence Park; Kathleen R Merikangas; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2019-12-09       Impact factor: 5.345

10.  Cooperative Studies Program (CSP) #572: A Study of Serious Mental Illness in Veterans as a Pathway to personalized medicine in Schizophrenia and Bipolar Illness.

Authors:  Philip D Harvey; Tim B Bigdeli; Ayman H Fanous; Yuli Li; Nallakkandi Rajeevan; Frederick Sayward; Krishnan Radhakrishnan; Grant Huang; Mihaela Aslan
Journal:  Pers Med Psychiatry       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.